Christopher Garabedian

Christopher Garabedian

Directeur Général chez
Xontogeny LLC
59 ans
Health Technology
Commercial Services
Consumer Services

Profil

Christopher Nishan Garabedian is the founder and currently holds the position of Chairman & Chief Executive Officer at Xontogeny LLC, which was founded in 2016.
He is also currently serving as Chairman at Bioharmony Therapeutics, Inc., Forge Biologics, Inc., Massachusetts Biotechnology Council, AsclepiX.
Therapeutics LLC, Zucara Therapeutics, Inc., VivoSense, Inc, Polycore Therapeutics, Inc., and Forge Biologics Holdings LLC.
Additionally, he is a Director at Massachusetts Biotechnology Council, AsclepiX.
Therapeutics LLC, Zucara Therapeutics, Inc., VivoSense, Inc, Polycore Therapeutics, Inc., and Forge Biologics Holdings LLC.
Mr. Garabedian is also a Portfolio Manager at Perceptive Advisors (Private Equity) since 2017.
Previously, he held the positions of President, Chief Executive Officer & Director at Sarepta Therapeutics, Inc. from 2012 to 2015, and Chairman at Landos Biopharma, Inc. from 2021 to 2024.
He has also served as a Director at Vyome Therapeutics, Inc. and Vice President-Corporate Strategy at Celgene Corp.
Mr. Garabedian completed his undergraduate degree at the University of Maryland.

Postes actifs de Christopher Garabedian

SociétésPosteDébut
Directeur Général 01/06/2016
Président -
Président -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Private Equity Investor 01/05/2017
░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Christopher Garabedian

SociétésPosteFin
░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ -
Voir l'expérience en détail de Christopher Garabedian

Formation de Christopher Garabedian

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Christopher Garabedian
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT